IPT-001 (HERVOLUTION Therapeutics)

N/A

Report date: 2024/12/26 11:02:08

Base Information

Drug NameIPT-001 (HERVOLUTION Therapeutics)
Drug Alias NameIPT-001 (HERVOLUTION Therapeutics)
ClassificationVaccines
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursDiabetes Mellitus, Type 2Prostatic Neoplasms +[6
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHERVOLUTION Therapeutics APS
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Prostatic NeoplasmsPancreatic Neoplasms
Inactive IndicationsSolid tumoursOvarian NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A